Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioAmber Inc. BIOAQ

BioAmber Inc is an industrial biotechnology company producing renewable chemicals. The company's proprietary technology platform combines industrial biotechnology and chemical catalysis to convert bio-based feedstocks into renewable chemicals that are cost-competitive replacements for petroleum-derived chemicals used in a wide variety of everyday products including plastics, resins, paints... see more

OTCPK:BIOAQ - Post Discussion

BioAmber Inc. > May 5 @ 1:00 PM - BNN Jerome Hass
View:
Post by dns236 on May 05, 2017 9:42am

May 5 @ 1:00 PM - BNN Jerome Hass

1:00 PM - Canadian mid-caps and long-short strategy 
Jerome Hass, Portfolio manager, Lightwater Partners 

His Feb.22'17 comments on BNN

Produces succinic acid, a base for an intermediate chemical or commodity that is used in a variety of things like plastic, polyurethane, and various other things. Generally made from petrochemical products, but their product is made from industrial sugars, which has a lot of advantages such as that it can be produced cheaper. It had 2 equity issues within 2 weeks which the market did not appreciate. The company has taken their knocks and are now cashed up essentially, so there shouldn’t be any more issues going forward.

Price:  $3.45
Bias:  CAUTIOUS
Owned:  Yes
Comment by dns236 on May 05, 2017 5:31pm
Jerome Hass fund still holds their shares of BioAmber and believe it's "still a very good story" but needs to show some sales and needs to operate plant @ 70-80% capacity. https://www.bnn.ca/market-call/jerome-hass-discusses-bioamber~1117003
Comment by dns236 on May 06, 2017 7:42am
BNN comments from Jerome Hass    2017-05-05  Price:  $2.21   "They produce a chemical that is used in a variety of products. Have the world’s biggest succinic acid plant. It seems that anything that could go wrong did. They did 2 financings which were not well received by the market. There was also a profit warning on their Q4 numbers. They had a shipment that was ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities